Skinvisible’s (OTCQB: SKVI) innovative DermSafe product incorporates the company’s proprietary Invisicare® drug delivery technology and has proven effective against a variety of infectious germs. An article discussing the topical and transdermal product development company reads: “The main curse this season is the particularly malevolent influenza virus H3N2. It is the most dominant strain not only in the U.S. but in Canada and the UK. The virus, experts believe, is mainly transmitted through the air by droplets formed when infected persons cough, sneeze or talk. These droplets land on hard surfaces like door knobs and as soon as one touches it they have just transferred the virus to their hands. With over 90 percent of all germs coming into one’s body from their hands, it is very important to wash them regularly. Regular use of an alcohol hand sanitizer will work as a replacement to hand washing, but it, too, is only immediate and offers no long term protection. Independent studies verify that DermSafe, when applied to the hands, offers a continuous long term kill on bacteria and viruses tested including the H3N2 virus. Consequently, a hand sanitizer like DermSafe is a vital safeguard against the spread of such germs.”
To view the full article, visit http://cnw.fm/1Yyqm
About Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit the company’s website at www.Skinvisible.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com